Latest / AudioScholar Rheumatology Weekly
Autoantibody-guided RA therapy no better than standard care
Editor's Pick: Exploring possibilities towards PeRsonalIsed MEdicine in Rheumatoid Arthritis (PRIMERA): tailored modifications to standard treat-to-target management-a multicentre, randomised, open-label trial (RMD Open, 2026)
Welcome to This Week in Rheumatology. This week we're covering 10 notable papers spanning treatment strategy and drug delivery in rheumatoid arthritis, the lung as a shared target across connective tissue disease, and how classification criteria, immunogenicity and age shape the patients in front of us. Let's dive in.
This week's papers:
Exploring possibilities towards…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.